Key result
A CD4+/CD8+ ratio ⩾1.725 was predictive of coronary plaque instability in patients with unstable angina pectoris, but failed to independently predict 1-year major cardiovascular events or all-cause mortality.
Why the study?
The association between the CD4+/CD8+ ratio and coronary plaque instability in patients with unstable angina pectoris had not been investigated.
Does the CD4+/CD8+ ratio predict coronary plaque instability and major adverse cardiovascular events in patients with unstable angina pectoris?
Cohort (n=266)
No
Does the CD4+/CD8+ ratio predict coronary plaque instability and major adverse cardiovascular events in patients with unstable angina pectoris?
While a higher CD4+/CD8+ ratio correlates with coronary plaque instability in UAP patients, it fails to independently predict 1-year MACE or all-cause mortality.
Answers are grounded in this paper and cite their sources.
May flag plaque instability in UAP but should not yet guide management; hypothesis-generating for immune markers in risk stratification.
BACKGROUND: The association between CD4+/CD8+ ratio and coronary plaque instability in patients with unstable angina pectoris (UAP) has not been investigated. We sought to elucidate the correlation between CD4+/CD8+ ratio and plaque instability in this patient population. METHODS: We enrolled 266 UAP patients who underwent pre-intervention optical coherence tomography (OCT) examination and percutaneous coronary intervention in our center from January 2016 to January 2018. Features of coronary plaques in the culprit arteries were classified as unstable plaque and stable plaque. Primary endpoint was occurrence of a major adverse cardiovascular event (MACE). Receiver operating characteristic (ROC) analyses were used to determine the predictive efficacy of the CD4+/CD8+ ratio for a group of unstable plaque patients, and binary logistic regression analysis was performed to evaluate potential independent predictors of plaque instability. All-cause mortality and MACE between the two groups were analyzed. ROC analyses showed that CD4+/CD8+ ratio ⩾1.725 was predictive of plaque instability in UAP patients. However, the Kaplan-Meier estimate for MACE and all-cause mortality showed no statistical significance. CONCLUSIONS: Higher CD4+/CD8+ ratio is associated with higher risk of plaque instability in our cohort of UAP patients. However, CD4+/CD8+ ratio was not an independent predictor of 1-year MACE or all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Chai et al. (2020) conducted a cohort in Unstable angina pectoris (UAP) (n=266). CD4+/CD8+ ratio was evaluated on Occurrence of a major adverse cardiovascular event (MACE). A CD4+/CD8+ ratio ⩾1.725 was predictive of coronary plaque instability in patients with unstable angina pectoris, but failed to independently predict 1-year major cardiovascular events or all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: